Refractory ascites
- PMID: 8303315
- DOI: 10.1055/s-2007-1007362
Refractory ascites
Abstract
The first step in the approach to the ascites patient, after the history and physical examination, is to perform a diagnostic abdominal paracentesis for SAAG to determine whether portal hypertension is present (SAAG 1.1 g/dl or higher) or not (SAAG less than 1.1 gm/dl) (Table 1). Patients without portal hypertension probably do not have liver disease as the cause of their ascites formation and probably should not be treated with dietary sodium restriction and diuretics. Patients with portal hypertension-related ascites usually have chronic parenchymal liver disease and usually require hospitalization for diet education, diuretic treatment, and evaluation of the underlying liver disease. Approximately 90% of patients with ascites due to chronic parenchymal liver disease respond to dietary sodium restriction and diuretics. Because of the poor prognosis associated with ascites, patients who are good candidates for transplantation should be considered for listing when they develop this complication of their underlying liver disease. The 10% of patients with cirrhosis whose ascites is refractory to routine medical treatment must be offered alternative therapy. Transplant candidates should be listed, in my opinion, once they are documented to have diuretic-resistant ascites. Fortunately, alcoholics (who are usually not good candidates for transplantation) who abstain from alcohol may revert from diuretic-resistant to diuretic-sensitive ascites over a period of months. Chronic outpatient therapeutic paracentesis is the most popular short-term treatment for patients with diuretic-resistant ascites. Paracentesis can be used as a "bridge" to alternative therapies or can be continued indefinitely.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.Gastroenterol Clin North Am. 1992 Mar;21(1):237-56. Gastroenterol Clin North Am. 1992. PMID: 1568775 Review.
-
Treatment of patients with cirrhosis and ascites.Semin Liver Dis. 1997;17(3):249-60. doi: 10.1055/s-2007-1007202. Semin Liver Dis. 1997. PMID: 9308129 Review.
-
Cirrhotic ascites: pathogenesis and management.Gastroenterologist. 1995 Mar;3(1):41-54. Gastroenterologist. 1995. PMID: 7743121 Review.
-
Management of ascites. A review.J Med. 1997;28(1-2):21-30. J Med. 1997. PMID: 9249607 Review.
-
Management of ascites in patients with end-stage liver disease.Rev Gastroenterol Disord. 2004 Fall;4(4):175-85. Rev Gastroenterol Disord. 2004. PMID: 15580152 Review.
Cited by
-
The use and misuse of transjugular intrahepatic portasystemic shunts.Curr Gastroenterol Rep. 2000 Feb;2(1):61-71. doi: 10.1007/s11894-000-0053-5. Curr Gastroenterol Rep. 2000. PMID: 10981005 Review.
-
Kidneys in chronic liver diseases.World J Gastroenterol. 2012 Jun 28;18(24):3035-49. doi: 10.3748/wjg.v18.i24.3035. World J Gastroenterol. 2012. PMID: 22791939 Free PMC article. Review.
-
Evaluation and management of patients with refractory ascites.World J Gastroenterol. 2009 Jan 7;15(1):67-80. doi: 10.3748/wjg.15.67. World J Gastroenterol. 2009. PMID: 19115470 Free PMC article. Review.
-
Hepatic disorders. Features and appropriate management.Drugs. 1995 Jan;49(1):83-102. doi: 10.2165/00003495-199549010-00007. Drugs. 1995. PMID: 7705218 Review.
-
Response Guided Slow Infusion of Albumin, Vasoconstrictors and Furosemide Improves Ascites Mobilization and Survival in Acute on Chronic Liver Failure: A Proof-of-Concept Study.J Inflamm Res. 2022 Sep 1;15:5027-5039. doi: 10.2147/JIR.S377494. eCollection 2022. J Inflamm Res. 2022. PMID: 36072778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources